Growth Metrics

ENDRA Life Sciences (NDRA) Assets Average (2017 - 2021)

Historic Assets Average for ENDRA Life Sciences (NDRA) over the last 5 years, with Q3 2021 value amounting to $16.3 million.

  • ENDRA Life Sciences' Assets Average rose 29588.38% to $16.3 million in Q3 2021 from the same period last year, while for Sep 2021 it was $16.3 million, marking a year-over-year increase of 29588.38%. This contributed to the annual value of $8.0 million for FY2020, which is 1071.03% up from last year.
  • ENDRA Life Sciences' Assets Average amounted to $16.3 million in Q3 2021, which was up 29588.38% from $18.1 million recorded in Q2 2021.
  • In the past 5 years, ENDRA Life Sciences' Assets Average ranged from a high of $18.1 million in Q2 2021 and a low of $517943.5 during Q1 2017
  • For the 5-year period, ENDRA Life Sciences' Assets Average averaged around $6.4 million, with its median value being $4.9 million (2018).
  • Data for ENDRA Life Sciences' Assets Average shows a peak YoY increase of 84737.86% (in 2018) and a maximum YoY decrease of 7187.83% (in 2018) over the last 5 years.
  • Over the past 5 years, ENDRA Life Sciences' Assets Average (Quarter) stood at $6.8 million in 2017, then tumbled by 37.41% to $4.3 million in 2018, then rose by 26.74% to $5.4 million in 2019, then soared by 30.9% to $7.1 million in 2020, then soared by 130.47% to $16.3 million in 2021.
  • Its last three reported values are $16.3 million in Q3 2021, $18.1 million for Q2 2021, and $13.8 million during Q1 2021.